TEVA - Urogen files patent suit against Teva over cancer therapy
2024-04-03 08:28:03 ET
More on Teva , UroGen Pharma, etc.
- Teva Pharmaceutical Industries: Potential Outweighs Concerns
- UroGen: All Eyes On UGN-102
- UroGen Pharma Ltd. (URGN) Q4 2023 Earnings Call Transcript
- Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent
- Teva and Launch Therapeutics collaborate for dual-action asthma rescue inhaler respiratory program